This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in ...

Rheumatoid arthritis is a crippling condition affecting 1.3 million people. To date, the standard of care has been to head ...

A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...

Adalimumab trough levels of 4.0 mg/L or higher among patients with RA were linked to greater treatment response and achievement of remission.

The AARP report suggests the spending cap could be huge for Medicare enrollees who take costly drugs for cancer, rheumatoid ...

Early treatment escalation to biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) following methotrexate (MTX) failure in new-onset rheumatoid arthritis (RA) does not ...

University of Birmingham researchers have been awarded £3.5 million funding from Johnson & Johnson to investigate mechanisms of response and non-response to biologic and targeted synthetic therapies ...

Rheumatoid arthritis ... has increased treatment options. Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in ...

Artificial intelligence (AI) can significantly aid in early detection of autoimmune diseases, like rheumatoid arthritis and ...